Sites
Support and structure for faster start-up, increased patient recruitment and consistent quality
Delivering benefits to patients and sites
We support all sites, from very experienced to research-naïve, reducing site burden to allow more time dedicated to patient care. Our site support can be customised to fit a particular protocol, or to fit individual site needs. From access to our global site network, to resourcing and engagement via Site Engagement Liaisons and Clinical Trial Liaisons, we can help sites operationlise their clinical research more efficiently, leading to faster timelines, better study data, and higher patient satisfaction.
- Accellacare Site Network Greater access to patients and multi-specialty physicians
- Accellacare Site Resourcing Qualified staffing support for clinical research sites
- FIRECREST Site portal Simplifies and streamlines study delivery for sites and study teams
- Accellacare In-Home Services Easing patient burden for increased retention
- Concierge Services Supporting patients for a more positive experience
- Digital Health Technologies Optimise protocol strategies with fit-for-purpose digital measures
Accellacare Site Network
Greater access to patients and multi-specialty physicians
Accellacare Site Resourcing
Qualified staffing support for clinical research sites
FIRECREST Site portal
Simplifies and streamlines study delivery for sites and study teams
Accellacare In-Home Services
Easing patient burden for increased retention
Concierge Services
Supporting patients for a more positive experience
Digital Health Technologies
Optimise protocol strategies with fit-for-purpose digital measures
In this section
- Asset Development Consulting
-
Blended Solutions
-
Cardiac Safety Solutions
-
Clinical & Scientific Operations
- Biostatistics
-
Case studies
- Clinical Operations
-
Clinical Supplies Management
- COVID-19
- Clinical data science
-
Endpoint Adjudication Services
- Global Logistics
- Interactive Response Technology
- Investigator Payments
-
Medical Affairs
-
Medical Call Centre Services
-
Medical Writing & Publishing
- Pharmacovigilance
-
Project and Program Management
-
Site Identification and Feasibility
- Commercial Positioning
- Decentralised Clinical Trials
- Early Clinical
- Language Services
-
Laboratories
- Medical Imaging
- Outcome Measures
- Real World Intelligence
- Regulatory Affairs
- Symphony Health data
- Site & Patient Solutions
- Strategic Solutions
-
Technologies
Related information:
Why using COAs and DHTs together is the future of clinical research
Though both COAs and DHTs are tools used to evaluate a treatment’s impact, they often exist in separate spheres. We argue that combining these two approaches in the same study can help researchers gather better data and improve the likelihood of regulatory approval.
Enhancing diversity in clinical trials
To fully assess the efficacy and safety of a therapeutic indication, clinical trials must evaluate populations that are representative of the treatment population, as different people may experience the same disease differently.
Sites
Support and structure for faster start-up, increased patient recruitment and consistent quality.
.jpg?crop=yes&w=555&h=291&a=0,25&itok=945IpOTm "RWD-webinar-2-(2)"){kind=icon}
The future of RWD and RWE in healthcare decision-making: Applications of novel real-world data collection methods for healthcare decision-making
Read insights from Jennifer Eriksson, Divisional Principal, on the use of real-world evidence and real-world data to inform healthcare decision-making and provide patients with rapid access to innovative healthcare technology.
Validating COAs: Key steps for accurate and reliable clinical trial data
With the increasing adoption of COAs, the importance of standardization across training, collection, and implementation to ensure high quality and consistent data collection has become apparent in recent decades.
DCT Tracker: Charting the next chapter for decentralisation
More than four years after decentralisation became a necessity in the clinical trials space, the sector is still finding its way around decentralised clinical trials (DCTs). And like any other paradigm shift, the journey has taken several turns.
Human-enabled AI driving enhancements in clinical trial site selection
In this piece from Clinical Trial Vanguard, Travis Caudill, Vice President, Feasibility, Site Identification & Clinical Informatics explores the improvements in site selection that human-enabled AI is delivering.
How human-enabled AI is creating a new map for navigating site selection
Discover how AI transforms site selection in clinical research by leveraging data and human expertise through an ecosystem approach to optimise site ranking, patient enrolment, and study timelines.
Embedded and agile – The next phase of the DCT evolution
This article highlights how DCTs are now considered a patient centric model for sponsors that want to enhance the patient and site experience and generate more robust data.
Site Training for Clinical Trial Success
Learn more about what you need to reduce risk, increase compliance and enhance quality with a comprehensive training solution.
Central to the mission
In this article from Pharmaceutical Executive, Harpreet Gill, VP of Real World Solutions - Project Management, discusses the progress and challenges in advancing data-driven tools and approaches in decentralised clinical trials.
.png?crop=yes&w=1382&h=725&a=0,99&itok=VyCRDhWc "ICON Hospital Shoot (12)"){kind=icon}
Early protocol assessment for increased patient centricity
In this article, Emily Mitchell, Executive Director, outlines how thorough assessment of protocols can ensure that studies are designed to minimise patient burden.